JONATHAN OLDAKER: Open Payments
NPI 1154881795 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 9 companies in 2025. Trend: 2023 $446 · 2024 $653 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $160 |
| Novo Nordisk Inc | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: BREZTRI, Ozempic, Wegovy, Cologuard Collection Kit, JARDIANCE, INJECTAFER, AIRSUPRA, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
